Profile
Camie Chan worked as an Assistant Professor at the University of California, Davis from 2006 to 2010.
From 2010 to 2016, she was the Deputy Director-Medicine Core Facility at the University of Hong Kong.
In 2019, she briefly served as the Chief Operating Officer & Director at Novoheart Holdings, Inc. Dr. Chan holds an undergraduate degree from The University of Waterloo and graduate and doctorate degrees from the University of Toronto.
Former positions of Camie Chan
| Companies | Position | End |
|---|---|---|
| University of Hong Kong | Corporate Officer/Principal | 2016-02-29 |
| University of California, Davis | Corporate Officer/Principal | 2009-12-31 |
| NOVOHEART HOLDINGS INC. | Director of Finance/CFO | - |
Training of Camie Chan
| The University of Waterloo | Undergraduate Degree |
| University of Toronto | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Novoheart Holdings, Inc.
 Novoheart Holdings, Inc. BiotechnologyHealth Technology Novoheart Holdings, Inc. is a global stem cell biotechnology company. It engages in engineering prototypes of bio-artificial human heart tissues and chambers for drug discovery, cardio toxicity screening, diseases modeling and therapeutic applications. The firm products include Human Ventricular Cardiomyocytes (hvCM), Cardiac Anisotropic Sheet (hvCAS), Cardiac Anisotropic Patch (hvCAP), Cardiac Tissue Strip (hvCTS), and novoHeart. The company was founded by Michelle Khine, Kevin Costa and Ronald Li on April 28, 1964 and is headquartered in Vancouver, Canada. | Health Technology |
- Stock Market
- Insiders
- Camie Chan
